X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2021/10/14/2314652/0/en/Onxeo-Further-strengthens-its-Board-of-Directors-with-two-Seasoned-Personalities-from-the-Healthcare-Sector.html
https://www.globenewswire.com/news-release/2021/07/29/2271586/0/en/Onxeo-Announces-the-Appointment-of-Dr-Shefali-Agarwal-as-the-Company-s-Chairwoman-of-the-Board.html
https://www.globenewswire.com/news-release/2020/11/09/2123061/0/en/Onxeo-Announces-Completion-of-Patient-Enrollment-in-DRIIV-1b-Study-and-Positive-Interim-Results.html
https://www.onxeo.com/onxeo-receives-notice-of-intent-to-grant-a-new-patent-enhancing-the-protection-in-europe-of-asidna-combined-with-parp-inhibitors/#:~:text=10%2F22%2F2020-,Onxeo%20Receives%20Notice%20of%20Intent%20to%20Grant%20a%20New%20Patent,%E2%84%A2%20Combined%20with%20PARP%20Inhibitors&text=This%20patent%20will%20provide%20a,compounds%2C%20alone%20or%20in%20combination.
https://www.onxeo.com/onxeo-announces-enrollment-of-first-patient-in-phase-ib-ii-study-revocan/#:~:text=Onxeo%20Announces%20Enrollment%20of%20First%20Patient%20in%20Phase%20Ib%2FII%20Study%20Revocan,-Revocan%20is%20designed&text=Paris%20(France)%2C%20October%2021,7%20pm%20CEST%20%2D%20Onxeo%20S.A.&text=Acquired%20resistance%20to%20targeted%20therapies,develop%20such%20a%20resistance3.
https://www.globenewswire.com/news-release/2020/09/03/2088686/0/en/Onxeo-Receives-Notice-of-Allowance-from-USPTO-for-New-Patent-Strengthening-Protection-of-AsiDNA-via-Systemic-Administration-in-the-United-States.html
https://www.globenewswire.com/news-release/2020/08/27/2084992/0/en/Onxeo-Reports-Publication-of-Final-Results-of-DRIIV-Phase-1-Dose-Escalation-Study-of-AsiDNA-in-Advanced-Solid-Tumors-in-the-British-Journal-of-Cancer.html
https://www.globenewswire.com/news-release/2020/06/25/2053221/0/en/Tizona-Initiates-Clinical-Development-of-TTX-080-in-Advanced-Cancers.html#:~:text=SOUTH%20SAN%20FRANCISCO%2C%20Calif.%2C,has%20been%20cleared%20by%20the
https://www.globenewswire.com/news-release/2020/05/29/2040664/0/en/Onxeo-Announces-Approval-of-the-REVocan-Study-by-Regulatory-Authorities.html
Market Place
Share 
